Company Profile

Id4pharma LLC
Profile last edited on: 5/17/18      CAGE: 70NW9      UEI: YP7FECLGFPU5

Business Identifier: Sequestosome- 1/p62- targeted small molecule Multiple Myeloma treatment
Year Founded
2015
First Award
2017
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1840 Mayview Road Suite 111
Bridgeville, PA 15017
   (832) 755-1105
   contact@id4pharma.com
   www.id4pharma.com
Location: Single
Congr. District: 18
County: Allegheny

Public Profile

Id4pharma LLC is an acronym for Intelligent Drug Design Discovery Development, as the company works to find a multiple Myeloma treatment. The company's goal is to handle FDA IND- studies of sequestosome-1 target specific small molecule drugs to present their Anti-MM drug to benefit Multiple Myeloma patients.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 2 NIH $2,306,840
Project Title: SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease

Key People / Management

  James J-H Lee -- CEO

  Jing-Zhou Hou -- Medical Advisor

  Yt Kwon

  Ying Mu -- Toxicologist and Pharmacologist

  David Roodman

  Chris L Waller

  Xiangqun Xie -- President

  Zhaojun (George) Xie -- Vice President

  L Harris Zhang -- Scientific Advisor

Company News

There are no news available.